UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

Operating profit fell by 86 per cent, and earnings per share slumped due to a settlement charge of £1.8bn related to the ...

PNY PRO Elite Prime microSD Flash Cards deliver impressive speed and performance for apps, games, high-res photography, and ...

Here's how to shop for a right-priced graphics card for playing games on today's best-value monitors—1,920 by 1,080 ...

NEW HAVEN, Conn. (WTNH) — Some top local politicians cut the ribbon Monday for a New Haven lab that works to test everyday products to make sure they don’t contain harmful chemicals.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

Like with any other graphics card, picking the best AMD GPU isn’t just about getting the fastest card on the market and ...

Matrox Video announced its role in Vizrt’s latest TriCaster product range, TriCaster Vizion, solidifying Matrox ... Read More ...

Takes you closer to the games, movies and TV you love Issues delivered straight to your door or device ...